Zhende Medical Co., Ltd. (SHA:603301)

Zhende Medical Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	992.95	596.16	1,052	2,075	1,358	1,809
Short-Term Investments	-	-	-	-	-	298.31
Trading Asset Securities	222.67	232.23	155.62	99.67	5.22	203.92
Cash & Short-Term Investments	1,216	828.39	1,207	2,175	1,364	2,311
Cash Growth	-30.15%	-31.39%	-44.48%	59.50%	-41.00%	236.58%
Accounts Receivable	703.2	764.06	550.51	793.96	694.52	671.15
Other Receivables	147.17	148.69	45.86	34.08	38.5	55.9
Receivables	850.37	912.74	596.37	828.04	733.02	727.05
Inventory	817.36	770.72	800.81	929.59	833.5	1,080
Other Current Assets	65.37	137.97	115.22	201.58	265.55	236.21
Total Current Assets	2,949	2,650	2,720	4,134	3,196	4,354
Property, Plant & Equipment	3,292	3,158	2,812	2,528	2,178	1,537
Long-Term Investments	193.48	194.27	195.07	137.81	84.83	-
Goodwill	794.61	788.78	787.83	474.49	398.52	130.42
Other Intangible Assets	702.09	710.12	607.1	564.46	444.82	225.62
Long-Term Deferred Tax Assets	65.5	65.25	79.5	53.4	56.03	39.53
Long-Term Deferred Charges	13.32	10.45	2.29	3.3	3.92	0.79
Other Long-Term Assets	124.28	-	62.78	-	60.35	112.83
Total Assets	8,134	7,577	7,267	7,896	6,422	6,400
Accounts Payable	476.29	399.62	325.25	646.77	576.83	636.27
Accrued Expenses	93.29	231.63	180.09	320.84	179.02	387.77
Short-Term Debt	706.94	300.19	281.97	165.55	660.73	358.37
Current Portion of Long-Term Debt	2.08	0.35	110.11	12.01	-	-
Current Portion of Leases	-	3	5.44	3.12	9.75	-
Current Income Taxes Payable	29.78	33.89	10	59.03	13.26	189.83
Current Unearned Revenue	29.87	26.21	44.88	144.39	47.84	88.19
Other Current Liabilities	200.85	165.15	214.56	167.02	115.18	78.76
Total Current Liabilities	1,539	1,160	1,172	1,519	1,603	1,739
Long-Term Debt	385.9	283.11	200.17	388.36	145.16	95.12
Long-Term Leases	1.13	1.52	39.23	36.81	32.73	-
Long-Term Unearned Revenue	220.63	218.02	231.98	176	173.9	91.02
Long-Term Deferred Tax Liabilities	16.94	17.78	18.64	20.05	27.68	7.86
Total Liabilities	2,164	1,680	1,662	2,140	1,982	1,933
Common Stock	266.45	266.45	266.45	266.45	227.2	227.2
Additional Paid-In Capital	1,787	1,787	1,787	1,782	895.61	1,021
Retained Earnings	3,654	3,602	3,351	3,552	3,009	2,936
Treasury Stock	-21.49	-21.49	-21.49	-36.56	-52.5	-
Comprehensive Income & Other	22.45	8.95	-17.71	-23.61	-12.42	-0.77
Total Common Equity	5,708	5,643	5,366	5,540	4,067	4,183
Minority Interest	262.77	253.15	238.8	215.32	372.86	284.11
Shareholders' Equity	5,971	5,896	5,604	5,756	4,440	4,467
Total Liabilities & Equity	8,134	7,577	7,267	7,896	6,422	6,400
Total Debt	1,096	588.17	636.92	605.85	848.36	453.48
Net Cash (Debt)	119.59	240.22	570.5	1,569	515.16	1,858
Net Cash Growth	-72.80%	-57.89%	-63.64%	204.55%	-72.27%	-
Net Cash Per Share	0.45	0.90	2.13	6.62	2.27	9.11
Filing Date Shares Outstanding	266.32	266.32	266.32	271.76	225.1	225.1
Total Common Shares Outstanding	266.32	266.32	266.32	271.76	225.1	225.1
Working Capital	1,410	1,490	1,548	2,615	1,593	2,615
Book Value Per Share	21.43	21.19	20.15	20.39	18.07	18.58
Tangible Book Value	4,211	4,144	3,971	4,502	3,223	3,827
Tangible Book Value Per Share	15.81	15.56	14.91	16.56	14.32	17.00
Land	-	18.39	21.99	1,386	-	-
Buildings	-	1,807	1,658	-	1,068	570.62
Machinery	-	1,630	1,453	1,175	1,084	742.43
Construction In Progress	-	562.33	388.39	513.97	514.07	577.94

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.